Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia

被引:0
作者
Raslova, Katarina [1 ]
Donicova, Viera [2 ]
Gonova, Katarina [3 ,4 ]
Klabnik, Alexander [5 ]
Tichy, Lukas [6 ,7 ]
Bridges, Ian [8 ]
Buckova, Dagmar [9 ]
Zachlederova, Marie [10 ]
Freiberger, Tomas [7 ,11 ]
Vohnout, Branislav [12 ,13 ,14 ]
机构
[1] Slovak Med Univ, Metab Ctr Ltd, Coordinat Familial Hyperlipidemias, Bratislava, Slovakia
[2] Outpatient Dept Internal Med & Diabetol, Kosice, Slovakia
[3] MedPed Lipid Clin, Internal Outpatient Clin, Piestany, Slovakia
[4] Slovak Med Univ, Fac Publ Hlth, Bratislava, Slovakia
[5] MedPed Lipid Clin, Cardiol Outpatient Clin, Namestovo, Slovakia
[6] Univ Hosp Brno, Ctr Mol Biol & Genet, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[7] Masaryk Univ, Med Fac, Brno, Czech Republic
[8] Amgen UK Ltd, Uxbridge, England
[9] Amgen Slovakia Sro, Bratislava, Slovakia
[10] Amgen Czech Republ Sro, Prague, Czech Republic
[11] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic
[12] Diabeda Sro, Diabet & Lipid Outpatient Clin, Bratislava, Slovakia
[13] Slovak Med Univ, Inst Nutr, Coordinat Ctr Familial Hyperlipidemias, Dept Diabet, Bratislava, Slovakia
[14] Comenius Univ, Sch Med, Dept Epidemiol, Bratislava, Slovakia
关键词
Familial hypercholesterolemia; Family screening; Registry; Cholesterol; Slovakia; RECOMMENDATION; ASSOCIATION; VARIANTS; CHILDREN;
D O I
10.1016/j.jacl.2024.03.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: In Slovakia, a mandatory national universal pediatric total cholesterol (TC) screening program is in place to identify cases of familial hypercholesterolemia (FH). However, the program's effectiveness has not been systematically assessed. OBJECTIVE: This study aimed to estimate the prevalence of FH among parents of children that had elevated TC levels identified during screening. METHODS: This prospective, non-interventional, observational study enrolled parents of 11-year- old children who underwent TC screening in 23 selected pediatric outpatient clinics between 2017 and 2018. FH was diagnosed using the Dutch Lipid Clinic Network (DLCN) criteria and targeted next- generation sequencing. The primary objective was to estimate the proportion of children with a TC level of > 188 mg/dL ( > 4.85 mmol/L) who had a parent with a confirmed diagnosis of FH. RESULTS: A total of 112 parents of 56 children with an elevated TC level were enrolled. Five children (8.9%) had a parent in whom FH was genetically confirmed. Without genetic analysis, all five parents would only be diagnosed with "possible FH" by DLCN criteria. Of parents, 83.9% ( n = 94/112) had an low-density lipoprotein cholesterol (LDL-C) level of > 116 mg/dL ( > 3 mmol/L), but only 5.3% ( n = 5/94) received lipid-lowering therapy. Among the five parents with genetically confirmed FH, all had an LDL-C level > 116 mg/dL ( > 3 mmol/L), with a mean ( +/- SD) of 191 ( +/- 24) mg/dL (4.94 [ +/- 0.61] mmol/L). Only two of these parents received lipid-lowering therapy. CONCLUSIONS: The present study demonstrates the significance of mandatory universal pediatric TC screening in identifying families with FH and other at-risk families in need of lipid-lowering therapy. (c) 2024 National Lipid Association. Published by Elsevier Inc. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:e537 / e547
页数:11
相关论文
共 40 条
  • [1] Characterization of the First PCSK9 Gain of Function Homozygote
    Alves, Ana Catarina
    Etxebarria, Aitor
    Medeiros, Ana Margarida
    Benito-Vicente, Asier
    Thedrez, Aurelie
    Passard, Maxime
    Croyal, Mikael
    Martin, Cesar
    Lambert, Gilles
    Bourbon, Mafalda
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (19) : 2152 - 2154
  • [2] Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)
    Averna, Maurizio
    Cefalu, Angelo B.
    Casula, Manuela
    Noto, Davide
    Arca, Marcello
    Bertolini, Stefano
    Calandra, Sebastiano
    Catapano, Alberico L.
    Tarugi, Patrizia
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2017, 29 : 11 - 16
  • [3] National Lipid Association Annual Summary of Clinical Lipidology 2016
    Bays, Harold E.
    Jones, Peter H.
    Orringer, Carl E.
    Brown, W. Virgil
    Jacobson, Terry A.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : S1 - S43
  • [4] Bedlington Nicole, 2022, GMS Health Innov Technol, V16, pDoc04, DOI 10.3205/hta000136
  • [5] Worldwide Prevalence of Familial Hypercholesterolemia Meta-Analyses of 11 Million Subjects
    Beheshti, Sabina O.
    Madsen, Christian M.
    Varbo, Anette
    Nordestgaard, Birge G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (20) : 2553 - 2566
  • [6] Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force Recommendation Statement
    Bibbins-Domingo, Kirsten
    Grossman, David C.
    Curry, Susan J.
    Davidson, Karina W.
    Epling, John W., Jr.
    Garcia, Francisco A. R.
    Gillman, Matthew W.
    Kemper, Alex R.
    Krist, Alex H.
    Kurth, Ann E.
    Landefeld, C. Seth
    LeFevre, Michael
    Mangione, Carol M.
    Phillips, William R.
    Phipps, Maureen G.
    Pignone, Michael P.
    Siu, Albert L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (06): : 625 - 633
  • [7] The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification
    Chora, Joana R.
    Iacocca, Michael A.
    Tichy, Lukas
    Wand, Hannah
    Kurtz, C. Lisa
    Zimmermann, Heather
    Leon, Annette
    Williams, Maggie
    Humphries, Steve E.
    Hooper, Amanda J.
    Trinder, Mark
    Brunham, Liam R.
    Pereira, Alexandre Costa
    Jannes, Cinthia E.
    Chen, Margaret
    Chonis, Jessica
    Wang, Jian
    Kim, Serra
    Johnston, Tami
    Soucek, Premysl
    Kramarek, Michal
    Leigh, Sarah E.
    Carrie, Alain
    Sijbrands, Eric J.
    Hegele, Robert A.
    Freiberger, Tomas
    Knowles, Joshua W.
    Bourbon, Mafalda
    [J]. GENETICS IN MEDICINE, 2022, 24 (02) : 293 - 306
  • [8] Lipid Screening in Children
    Daniels, Stephen R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (11) : 1258 - 1260
  • [9] Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity
    Fernandez-Higuero, J. A.
    Etxebarria, A.
    Benito-Vicente, A.
    Alves, A. C.
    Arrondo, J. L. R.
    Ostolaza, H.
    Bourbon, M.
    Martin, C.
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [10] Phenotypic and genotypic characterization of familial hypercholesterolemia in French adult and pediatric populations
    Fourgeaud, Melanie
    Lebreton, Louis
    Belabbas, Khaldia
    Di Filippo, Mathilde
    Rigalleau, Vincent
    Couffinhal, Thierry
    Pucheu, Yann
    Barat, Pascal
    Ged, Cecile
    Berard, Annie M.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (03) : 298 - 305